Long Cycles with PCOS: What 35 to 90 Day Cycles Mean for TTC

Your cycles run 40 to 70 days, sometimes longer. You feel like everyone else is getting 12 chances per year and you are getting six or seven. The first thing I want you to hear is that a 50-day PCOS cycle is not failure. It is a longer follicular phase ending in ovulation, often a normal one. The second thing is that long cycles have real practical consequences for how often you can try, how to interpret the fertile window, and when to escalate, and those consequences are worth thinking about clearly.

The phrase fertile window describes the days each cycle when intercourse can lead to conception, which is essentially the five days before ovulation and the day of ovulation itself. In a 28-day cycle the window typically sits around cycle days 10 to 15. In a 50-day PCOS cycle it might land on days 30 to 35. The window is always relative to when you ovulate, not to a fixed calendar day, which is why people with PCOS cannot calendar-predict in advance and have to track signals instead.

What "long cycle" actually means

The 2023 International Evidence-Based Guideline for PCOS defines irregular cycles as cycles longer than 35 days, fewer than eight cycles per year, or cycle-to-cycle variation greater than nine days.¹ So the term "long cycle" in a clinical sense usually means a cycle that runs longer than 35 days. The Bull 2019 dataset of more than 600,000 cycles tracked through a fertility app found that around 87 percent of cycles fell between 22 and 35 days; cycles longer than that were the minority in the general population, but they are the norm in PCOS.³

A long cycle is not automatically an anovulatory cycle. A 50-day cycle that includes a confirmed ovulation around day 36 is long but ovulatory. A 50-day cycle with no LH surge, no BBT shift, and no progesterone rise is anovulatory. The distinction matters because:

• A 50-day ovulatory cycle gives you fewer chances per year but each chance has roughly normal probability.
• A 50-day anovulatory cycle is a non-chance month.

I cover the distinction in detail in anovulatory cycles explained.

Why PCOS cycles run long

The follicular phase is the variable half of the cycle, and PCOS specifically prolongs it. The mechanism is several layers deep:

• The pituitary gland produces an LH:FSH ratio that is typically tilted toward LH, which weakens the FSH pulse the brain delivers in the early follicular phase.
• Many small antral follicles are recruited but none crosses the selection threshold to become the dominant follicle promptly. The ovary tries, recruits again, and tries again. Each attempt extends the follicular phase.
• Insulin resistance, which sits under most PCOS, raises androgen production from the ovaries and adrenal glands. Elevated androgens further disrupt follicular selection.
• High anti-Müllerian hormone, common in PCOS, reflects a large antral follicle pool but does not translate into faster selection.

The luteal phase, by contrast, is usually normal in PCOS when ovulation does occur. So the 12 to 14 day window from ovulation to next period stays roughly constant; it is just preceded by a much longer follicular phase.¹ I cover the diagnostic side in PCOS workup essentials.

How many chances per year you actually have

This is the maths that often gets skipped, and it explains a lot of how time-to-pregnancy feels in PCOS.

Average cycle length	Cycles per year
28 days	13.0
35 days	10.4
50 days	7.3
60 days	6.1
90 days	4.0

If your cycles run 50 days, you get roughly seven ovulatory attempts in 12 calendar months, compared with 13 for someone on a 28-day cycle. Per-cycle pregnancy probability with optimal timing in healthy couples under 35 is about 20 to 33 percent.⁵ If your per-cycle probability is similar, you are still looking at meaningful cumulative odds over a year, just spread over fewer chances.

The practical implication is that time-to-pregnancy in calendar months is longer in PCOS, even when per-cycle probability is normal. That is not a failure. It is the maths of having fewer chances per year. It is also part of why the 2023 PCOS Guideline supports evaluation at six months rather than 12 in PCOS, because waiting the full year would mean only four to seven actual ovulatory attempts before evaluation.¹

Where the fertile window is in a long cycle

In a 28-day cycle, predicting the fertile window from the calendar mostly works. In a 50-day cycle, calendar prediction fails completely. The fertile window in a long cycle is still 5 to 6 days wide, centred on ovulation, but you cannot know in advance where ovulation will fall in any given cycle. You have to track signals.

The most reliable practical anchor is the luteal phase. Because it is typically 12 to 14 days from ovulation to period, you can:

• Retrospectively: subtract 14 days from the start of your next period to estimate when ovulation happened in the cycle just ended. This is the easiest sanity-check after the fact.
• Prospectively: rely on cervical mucus and OPKs through whatever extended window your cycles take, rather than calendar prediction.

The Wilcox 2000 prospective study established that even in regular-cycle women, the fertile window varied by several days across cycles, and a meaningful proportion of women experienced ovulation outside the textbook "day 10 to 17" range.⁴ In PCOS, that variability is greater. I cover the wider-than-expected nature of the fertile window in fertile window wider than you think.

Tracking strategy for long cycles

If your cycles run 40 to 70 days, the tracking strategy has to be adjusted from the standard "test OPK from cycle day 10 to 17" advice. A few specifics:

1. Use bulk strip OPKs, not digital kits. Digital kits are expensive and the running cost of testing daily across a 50-day cycle is prohibitive. Strip OPKs are a few cents each.
2. Start OPK testing on cycle day eight or ten and continue indefinitely until you get a clear positive, with the strip pattern showing the test line equal to or darker than the control line. Do not stop at day 20 or day 25.
3. Check cervical mucus two to three times a day, every day: in a long cycle the EWCM peak can appear unexpectedly, and you do not want to miss it because you stopped checking.
4. Take BBT daily under consistent conditions. The BBT shift is retrospective confirmation; it tells you ovulation happened, but it is days late for timing purposes.
5. Time intercourse every one to two days through any positive OPK and for several days after.

I cover the practical mechanics in timing intercourse with irregular PCOS cycles.

When a long cycle is just long versus when it is anovulation

The signal that distinguishes the two is whether ovulation eventually happened.

Long-but-ovulatory: there is a positive OPK at some point (often late, but real), followed by a sustained BBT shift, followed by a period 12 to 14 days after the shift. If a progesterone is drawn seven days after the suspected ovulation, it is above 3 ng/mL.

Long-and-anovulatory: no positive OPK, no BBT shift, no progesterone rise, and the eventual bleed is irregular in timing and volume. The "period" is anovulatory bleeding rather than a true luteal-phase bleed.

The 2023 PCOS Guideline frames chronic oligo-ovulation (cycles greater than 35 days with infrequent ovulation) as a PCOS feature, while chronic anovulation (no ovulation across consecutive cycles) is a stronger signal for treatment.¹ The distinction often only becomes clear across two to three cycles of tracking, and a mid-luteal progesterone draw is the most efficient way to settle it for any given cycle.

When to escalate to medication

There is a reasonable decision frame here, drawn from the 2023 Guideline.

• TTC + PCOS + 6+ months without conception: the Guideline supports evaluation and likely ovulation-induction treatment now.¹ You do not need to wait the full 12 months that applies to couples with no known fertility factor.
• Cycles consistently 50+ days: a discussion of ovulation induction at three to six months of TTC is reasonable. The maths of getting only six or seven chances per year shifts the cost-benefit toward earlier medication.
• Cycles 35 to 50 days with confirmed ovulation: natural-cycle trying for the full six months is reasonable, particularly if you are under 35 and have no other concerns.
• No period for 90+ days outside pregnancy: contact your clinician now, regardless of TTC status. A short course of an oral progestin to induce a withdrawal bleed protects the endometrium and resets the cycle.

I cover the year-rule exceptions in detail in when the year rule doesn't apply.

What treatment changes

When letrozole or clomiphene is started for PCOS ovulation induction, the most immediate effect is on the follicular phase. The 2014 PALO trial established letrozole as the first-line oral ovulation-induction agent for PCOS, with a cumulative live-birth rate of 27.5 percent over five cycles, compared with 19.1 percent for clomiphene.²

In practical terms:

• Letrozole-induced ovulation typically occurs on cycle day 12 to 18, compared with day 30 to 50 naturally.
• This restores roughly 12 to 13 cycles per year rather than six to eight.
• The cumulative gain over six cycles of letrozole in PCOS is meaningful. PALO showed 27.5 percent live births over five cycles in PCOS; broader real-world cohorts suggest cumulative live-birth rates of roughly 60 to 75 percent over six cycles when there are no other infertility factors.

The point of medication is more cycles per calendar year, on top of any per-cycle improvement. Going from seven chances to 13 is a 1.8x increase in attempts before any per-cycle gain is counted. I cover letrozole in detail in letrozole for PCOS overview.

What is normal, what is a flag

Normal in PCOS: cycles 35 to 60 days with confirmed ovulation, six to ten ovulatory cycles per year, occasional anovulatory cycle interspersed.

Worth discussing with your clinician: cycles consistently over 60 days, no period for 90+ days, chronic anovulation across multiple cycles, signs of estrogen excess (heavy bleeding, prolonged bleeding), or TTC for six or more months with PCOS.¹

Red flag: bleeding heavy enough to require changing a pad every hour, prolonged bleeding lasting more than seven days, severe pelvic pain, or any sign of pregnancy complication on top of an irregular bleed.

What you can do tonight

1. If you have not had a period in 90 days, contact your clinician this week. A short course of an oral progestin to induce a withdrawal bleed is a small, safe intervention worth doing rather than waiting.
2. If you are TTC and your cycles consistently run 50+ days, schedule a consult to discuss letrozole. The maths of fewer chances per year is the reason to consider escalation earlier.
3. If your cycles run 35 to 45 days with confirmed ovulation and you are under 35, continuing natural-cycle trying for six months is reasonable.
4. Track every cycle in detail. The pattern across three to six months is the data your clinician needs to decide what to do next.
5. Use cervical mucus and OPK rather than calendar prediction. The calendar will not help in a long cycle.

What's next

• For the pattern context, the pillar: anovulatory cycles explained
• For timing intercourse in irregular cycles: timing intercourse with irregular PCOS cycles
• For understanding the fertile window in detail: fertile window wider than you think
• If your ovulation is late rather than absent: late ovulation: normal, concerning, or both
• For escalation: when the year rule doesn't apply and letrozole for PCOS overview

Sources

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
2. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine 2014;371(2):119-129. https://www.nejm.org/doi/full/10.1056/NEJMoa1313517
3. Bull JR, Rowland SP, Scherwitzl EB, Scherwitzl R, Danielsson KG, Harper J. Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles. NPJ Digital Medicine 2019;2:83. https://doi.org/10.1038/s41746-019-0152-7
4. Mumford SL, Steiner AZ, Pollack AZ, et al. The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. Journal of Clinical Endocrinology & Metabolism 2012;97(10):E1871-E1879. https://doi.org/10.1210/jc.2012-1350
5. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertility and Sterility 2008;90(5 Suppl):S219-S225. https://doi.org/10.1016/j.fertnstert.2008.08.038